This inventor holds 11 USPTO granted patents, plus 1 CIPO patent. Top assignees: Takeda Chemical Industries, Inc., Takeda Limited Industries, Ltd.. Active years: 1995-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kawanishi, JP (1995 - 1999)
- Hyogo, JP (1997 - 2001)
Company Filing History:

Years Active: 1995-2001
Title: **Innovator Tsutomu Kurokawa: Pioneering Advances in Biochemistry**
Introduction
Tsutomu Kurokawa, based in Kawanishi, Japan, is a prominent inventor known for his contributions to biochemistry. With a remarkable portfolio that includes 11 patents, Kurokawa has made significant strides in the field, particularly in the development of xanthene derivatives and monoclonal antibodies.
Latest Patents
Among Kurokawa's latest patents, two stand out for their innovative approaches. The first patent focuses on "Xanthene derivatives, their production and use," showcasing his advancement in the synthesis and application of xanthene compounds. The second patent involves "Monoclonal antibody, hybridoma, their production and use thereof," which details the production of monoclonal antibodies from cloned hybridomas. This specific monoclonal antibody is designed to interact selectively with basic fibroblast growth factor (bFGF), offering potential applications in assay reagents and bFGF purification.
Career Highlights
Kurokawa has had a distinguished career, working with prestigious organizations such as Takeda Chemical Industries, Inc. and Takeda Limited Industries, Ltd. His tenure at these companies has allowed him to harness his innovative spirit and contribute valuable research that has had a lasting impact on biochemistry.
Collaborations
Throughout his career, Kurokawa has collaborated with notable coworkers, including Koichi Igarashi and Ken-ichi Kuroshima. Their combined expertise has fostered a collaborative environment that promotes groundbreaking research and development in their respective fields.
Conclusion
Tsutomu Kurokawa exemplifies the essence of innovation in biochemistry through his patents and collaborative efforts. His work not only advances scientific understanding but also opens new avenues for practical applications, which can benefit various sectors within the pharmaceutical and biotechnology industries. As he continues to explore the boundaries of science, Kurokawa remains an inspiration for future inventors and researchers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile